May 14, 2020 / 9:56 PM / 21 days ago

BRIEF-Plus Therapeutics Q1 Loss Per Share $0.28 From Continuing Operations

May 14 (Reuters) - Plus Therapeutics Inc:

* PLUS THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL AND BUSINESS RESULTS

* Q1 LOSS PER SHARE $0.28 FROM CONTINUING OPERATIONS

* ENDED Q1 2020 WITH APPROXIMATELY $16.1 MILLION OF CASH AND CASH EQUIVALENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below